Alto Neuroscience, Inc.
ANRO
$34.35
-$1.46-4.08%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.64M | -26.24M | -16.18M | -14.18M | -17.71M |
| Total Depreciation and Amortization | 184.00K | 184.00K | 157.00K | 164.00K | 169.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.05M | 3.36M | 2.41M | 2.80M | 2.46M |
| Change in Net Operating Assets | 3.64M | -4.39M | 2.10M | 1.30M | 1.30M |
| Cash from Operations | -19.76M | -27.09M | -11.52M | -9.92M | -13.78M |
| Capital Expenditure | 0.00 | -556.00K | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -556.00K | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 750.00K |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 75.00K | 120.01M | 50.35M | 153.00K | 0.00 |
| Repurchase of Common Stock | 0.00 | -190.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -348.00K | -4.88M | -167.00K | 0.00 | -137.00K |
| Cash from Financing | -273.00K | 114.94M | 50.19M | 153.00K | 613.00K |
| Foreign Exchange rate Adjustments | 4.00K | -16.00K | -1.00K | -4.00K | -3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.03M | 87.28M | 38.67M | -9.77M | -13.17M |